Healthcare
Accel, Kitven back Mitra Biotech
Accel Partners and local Indian VC Karnataka Information Technology Venture Capital Fund (Kitven) have jointly invested an undisclosed amount in Mitra Biotech, which is developing a personalized cancer diagnostic platform.
Goldman due 200x return in China pharma IPO
With the Shenzhen IPO of little-known Chinese pharmaceutical company Shenzhen Hepalink Pharmaceutical, Goldman Sachs will see an almost certain 200-fold profit on its original $5 million investment.
Industry Q&A: Norman Chen, Partner, Fidelity Asia Ventures
Chen talks to AVCJ’s Paul Mackintosh about opportunities for healthcare investments in China
Carlyle may part exit Claris
The Carlyle Group is likely to exit at least part of its almost 14% stake in Indian drugs firm and IPO candidate Claris Lifesciences, according to reports.
AIF announces Famy India contraceptive deal
AIF Capital has announced that AIF Capital Asia III LP and its affiliates have invested $40 million into Famy Care Ltd., a Mumbai-based pharmaceuticals manufacturer.
Trikona exiting Fortis
Trikona Trinity Capital, a listed private equity firm floated on London's AIM board, is reportedly exiting its pre-IPO investment in India's Fortis Healthcare in stages.
Healthcare: The next China VC horizon?
Although it doesn't always register prominently on the radar, healthcare and related biotech actually accounts for 30% or more of all venture capital investment in the US.
Sequoia invests PRC blood glucose business
Sequoia Capital has led a $10.25 million Series A investment round into Beijing YiCheng Bioelectronics Technology Co. Ltd., a blood glucose monitoring system manufacturer.
Apax may pick up ICICI Metropolis stake
London-headquartered private equity group Apax Partners is emerging as the probable buyer of the 25% stake in India's Metropolis Healthcare held by ICICI Venture, for a probable deal value of around $45 million.
OrbiMed invests Bharat Serums
Healthcare specialist investor OrbiMed Advisors has invested an undisclosed amount in Indian pharma biotech business Bharat Serums and Vaccines Ltd., in its second deal on the Subcontinent.
IDG, SBI, others back China biotech
A VC investor group led by IDG-Accel, SBI & TH Venture Capital Enterprise, has made an investment totaling $16 million in OriGene Technologies, Inc., a Chinese gene-centric life sciences device company dedicated to support academic, pharmaceutical and...
Sequoia invests 91Huayi.com
Sequoia Capital China has reportedly invested RMB30 million ($4.4 million) in 91Huayi.com, a Chinese medical information and education website.
CHAMP to offload Healthcare Australia
Australian buyout firm CHAMP Private Equity is reportedly exploring ways to sell its Healthcare Australia business, a transaction that could come in at A$320 million ($292.5 million).
IFC promotes health in China
The International Finance Corporation (IFC) has agreed to invest $25 million in Singapore-based Healthway Medical Corporation Ltd for development of medical care facilities “in under-served areas of China,” the group said.
TPG exits Parkway for $685 million
TPG Capital has sold its 23.9% stake in Singapore hospital operation Parkway Holdings to Indian healthcare group Fortis Healthcare for $685.3 million.
Symphony partially exits Strides Arcolab
Symphony Capital has sold shares in its long-term Indian medical investment Strides Arcolab, equivalent to just under $5 million.
Fidelity Asia invests PRC medical device distributor
Fidelity Asia Ventures, the Asian venture and growth capital arm of Fidelity International Ltd and its US affiliate Fidelity Biosciences, has jointly invested $10 million in TCT Medical, which claims to be the largest medical device distributor and service...
Yorkville invests $10 million in Chinese pharma company
Yorkville Advisors, a US financial firm specializing in providing debt and equity financing to listed companies globally, has injected $10 million into Lotus Pharmaceutical, Inc., a US OTC Bulletin Board-listed company engaged in the production, trading...
Tokio Marine takes over Bushu Pharmaceuticals
Tokio Marine Capital, the Japanese private equity arm of Tokio Marine & Nichido Fire Insurance Co., Ltd. will acquire 100% of Bushu Pharmaceuticals, a provider of drug manufacturing services, from listed company Shionogi Pharmaceuticals.
Wipro chairman backs Manipal through PremjiInvest
PremjiInvest, the $1 billion private equity vehicle backed by Wipro Group chairman Azim Premji, will invest some $43.3 million for a significant minority stake in Manipal Universal Education, the corporate education arm of Manipal Education and Medical...
Baring India ahead on Famy Care
Baring Private Equity Partners India is reportedly close to acquiring 15% of Mumbai-based contraceptive device and oral contraceptive maker Famy Care, for some $40 million.
JAIC takes over elderly care business
Japan Asia Investment Co. (JAIC), the Tokyo-based venture firm, has acquired all the shares of Healthy Service Co., an elderly care and nursing services provider in central Japan.
Goldman gets Max India
Goldman Sachs direct investment unit Goldman Sachs Capital Partners has won out over reported interest from Kohlberg Kravis Roberts & Co. in the acquisition of Indian healthcare and insurance provider Max India Ltd.
KKR may go to the Max
Kohlberg Kravis Roberts & Co. reportedly may commit up to $117 million into Max India Group, the investment holding company of healthcare and insurance entrepreneur Analjit Singh.